The home as an appropriate setting for women undertaking cervical ripening before the induction of labour.
OBJECTIVE
to explore women's experiences of cervical ripening using isosorbide mononitrate (IMN) in the home as part of the main randomised controlled trial.


METHODS
qualitative study with semi-structured interviews carried out at three weeks post partum. Interview transcripts were analysed to identify recurrent themes, focusing on why women became involved in the study, their views about both the self-medication and the home setting, and whether they would repeat the experience.


METHODS
the home.


METHODS
twenty women enrolled in the main randomised controlled trial.


METHODS
the study is part of a double-blind randomised controlled trial with 350 patients investigating whether a nitric oxide donor (IMN) used in cervical ripening improves the process of induction of labour.


RESULTS
women liked the opportunity to remain at home during the cervical ripening process. Timing and setting were central issues; women hoped that it would hasten labour, while the home was seen as a setting offering freedom, security and reassurance, as opposed to the hospital, seen as constraining. Two women reported problems with IMN but the remainder reported that they would repeat the experience.


CONCLUSIONS
women were very positive about the opportunity to undertake cervical ripening at home. It is important to explore this setting further for appropriate interventions.
Reid
Margaret
M
Public Health and Health Policy, Division of Community Based Sciences, University of Glasgow, Glasgow, UK. m.e.reid@clinmed.gla.ac.uk
Lorimer
Karen
K
Norman
Jane E
JE
Bollapragada
Shrikant S
SS
Norrie
John
J
D000282:Administration, Intravaginal; D000328:Adult; D000553:Ambulatory Care / Q000379:methods* / Q000523:psychology; D020070:Cervical Ripening / Q000187:drug effects*; D020008:Delavirdine / Q000008:administration & dosage; D005260:Female; D006699:Home Care Services; D006801:Humans; D007548:Isosorbide Dinitrate / Q000008:administration & dosage / Q000031:analogs & derivatives*; D007751:Labor, Induced / Q000379:methods*; D020030:Nitric Oxide Donors / Q000008:administration & dosage*; D017060:Patient Satisfaction / Q000706:statistics & numerical data*; D011247:Pregnancy; D006113:United Kingdom; D055815:Young Adult
D020030:Nitric Oxide Donors; D020008:Delavirdine; D007548:Isosorbide Dinitrate; C030397:isosorbide-5-mononitrate